Form 4 for ANIX Anixa Biosciences Inc
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001493152-22-017926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-28 | 2022-06-24 | ANIX | Titterton Lewis H jr | Dir | M - OptEx | $2.58 | +46.0K | 1.03M | +5% | +$118.7K |
| DM | 2022-06-28 | 2022-06-24 | ANIX | Titterton Lewis H jr | Dir | M - OptEx | $0.00 | -46.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-24 | M | A | 30,000 | $2.58 | 1,018,070 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-24 | M | A | 16,000 | $2.58 | 1,034,070 | D | — | — | |
| 3 | Derivative | Employee Stock Option | 2022-06-24 | M | D | 16,000 | $0.00 | 0 | D | $2.58 · 2013-03-28 to 2022-12-31 | 16,000 Common Stock | (F2) Right-To-Buy, pursuant to a stock option grant dated March 28, 2013. |
| 4 | Derivative | Employee Stock Option | 2022-06-24 | M | D | 30,000 | $0.00 | 0 | D | $2.58 · 2012-09-19 to 2022-09-19 | 30,000 Common Stock | (F1) Right-To-Buy, pursuant to a stock option grant dated September 19, 2012. |